Omega Fund Management as of Dec. 31, 2025
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 11 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvation Bio Common Stock Class A (NUVB) | 25.3 | $72M | 8.1M | 8.96 | |
| BridgeBio Oncology Therapeutics Common Stock (BBOT) | 14.4 | $41M | 3.3M | 12.52 | |
| Beta Bionics Common Stock (BBNX) | 14.0 | $40M | 1.3M | 30.47 | |
| Bicara Therapeutics Common Stock (BCAX) | 12.9 | $37M | 2.2M | 16.83 | |
| Kestra Med Technologies Common Stock (KMTS) | 12.7 | $36M | 1.4M | 26.52 | |
| Upstream Bio Common Stock (UPB) | 12.6 | $36M | 1.3M | 27.15 | |
| enGene Holdings Common Stock (ENGN) | 2.8 | $7.9M | 876k | 9.03 | |
| Alumis Common Stock (ALMS) | 2.2 | $6.4M | 653k | 9.76 | |
| Sana Biotechnology Common Stock (SANA) | 1.2 | $3.4M | 844k | 4.07 | |
| ImageneBio Common Stock (IMA) | 1.1 | $3.1M | 455k | 6.90 | |
| Replimune Group Common Stock (REPL) | 0.8 | $2.4M | 249k | 9.72 |
